Skip to main content
CRI
NYSE Manufacturing

Carter's Q2 Sales Rise 5%, Adjusted EPS Up 53%; Tariff Refund Boosts Cash

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Retail Stocks · Consumer
Sentiment info
Neutral
Importance info
7
Price
$37
Mkt Cap
$1.393B
52W Low
$23.381
52W High
$44.44
52W Position info
58% above low
Off High info
17% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

CRI sits 58% above its 52-week low of $23.381.

Summary

Carter's posted Q2 2026 net sales of $615 million, up 5% year-over-year, and adjusted diluted EPS of $0.26, a 53% increase. The company also received a $132 million tariff refund and updated its full-year guidance, projecting a high single-digit to low double-digit decline in adjusted EPS.


Key Events · Earnings and Guidance · CRI

  • Q2 Sales and Earnings Beat

    Net sales rose 5.2% to $615.5 million, with U.S. Retail comparable sales up 5.1%. Adjusted operating income grew 54% to $18.1 million, and adjusted diluted EPS increased 53% to $0.26.

  • Tariff Refund Windfall

    A recovery of $132 million ($100 million after-tax) in previously paid import duties and related interest significantly boosted reported GAAP net income to $105 million ($2.87 per share) and operating cash flow to $202 million in the first half.

  • Full-Year Guidance Implies EPS Decline

    The fiscal 2026 outlook projects 2-3% net sales growth but a high single-digit to low double-digit decline in adjusted diluted EPS, reflecting incremental tariff costs and investment spending.

  • New CEO Commentary

    New CEO Sharon Price John highlighted improved marketing, productivity initiatives, and progress in the Baby segment, while noting the opportunity to unlock value and drive profitable growth.


Analysis · CRI · Manufacturing

A solid second quarter saw Carter's deliver 5% sales growth and a 53% surge in adjusted earnings per share, fueled by robust U.S. retail comparable sales and productivity gains. The period also featured a one-time $132 million tariff refund that materially lifted reported profits and cash flow. Yet the full-year outlook points to a high single-digit to low double-digit decline in adjusted EPS, underscoring persistent tariff and investment headwinds. In her first public remarks, the new CEO signaled strategic continuity while acknowledging the need to unlock value.

At the time of this filing, CRI was trading at $37.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $23.38 to $44.44. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CRI - Latest Insights

CRI
Jul 31, 2026, 6:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $38.80
Real-time Price: $37.00 info
Change: -$1.80 (-5%) info
Market Cap: $1.393B info
CRI
May 14, 2026, 4:31 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $33.76
Real-time Price: $37.00 info
Change: +$3.24 (+10%) info
Market Cap: $1.393B info
CRI
May 06, 2026, 12:08 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $38.85
Real-time Price: $37.00 info
Change: -$1.84 (-5%) info
Market Cap: $1.393B info
CRI
May 06, 2026, 6:17 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $33.34
Real-time Price: $37.00 info
Change: +$3.66 (+11%) info
Market Cap: $1.393B info
CRI
May 06, 2026, 6:10 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $33.34
Real-time Price: $37.00 info
Change: +$3.66 (+11%) info
Market Cap: $1.393B info